Health Canada warns doctors not to start this prescription medication CTV NewsMark Hensley: The Hidden Risks of Changing Clinical Trial Endpoints After Unblinding OncodailyControversial drug at center of multibillion-dollar Amgen deal faces more questions after paper retracted The Business JournalsMedical journal retracts paper on Amgen’s Tavneos drug trial after FDA findings Reuters
